Three questions from the exam
These are three of the 100, with every option explained, so you can judge the style before you buy.
Sample question 9
A pharmacist reconstitutes amoxicillin 400 mg/5 mL powder for oral suspension. According to the manufacturer's labeling, what discard date should the label carry?
- A. Discard after 3 days
- B. Discard after 14 days
- C. Discard after 30 days
- D. Discard after 90 days
- E. Discard after 6 months
Show the answer and explanations
Answer: B.
- A. Three days is shorter than the labeled stability of 14 days.
- B. Correct. Reconstituted amoxicillin suspension is stable for 14 days when kept in a tightly closed container and shaken well before each use; refrigeration is preferable but not required. This is the manufacturer's labeled instruction, not the USP <795> default for compounded preparations.
- C. Thirty days exceeds the stability limit.
- D. Ninety days exceeds the stability limit.
- E. Six months exceeds the stability limit.
Sample question 10
A patient presents a Schedule IV prescription written 7 months ago with 3 refills remaining. May the pharmacist dispense it under federal law?
- A. Yes, because refills remain on the prescription
- B. Yes, but only one of the three refills
- C. No, because Schedule IV drugs may never be refilled
- D. No; it is more than six months past the date issued
- E. Yes, if the patient pays cash for the fill
Show the answer and explanations
Answer: D.
- A. Remaining refills do not extend the six-month limit.
- B. No refill is permitted after six months.
- C. Schedule III and IV drugs may be refilled, subject to those limits.
- D. Correct. A CIII-CIV prescription may not be filled or refilled more than six months after issue, or refilled more than five times (state law may be stricter).
- E. The payment method has no bearing on the limit.
Sample question 47
Which of the following is on The Joint Commission's official "Do Not Use" list of abbreviations?
- A. BID (twice daily)
- B. U (unit)
- C. PRN (as needed)
- D. mg (milligram)
- E. IV (intravenous)
Show the answer and explanations
Answer: B.
- A. BID is not on the list, although individual organizations may discourage it and local policy can be stricter.
- B. Correct. "U" can be mistaken for 0, 4, or cc; write "unit".
- C. PRN is not on the list.
- D. mg is the standard abbreviation for milligram and is not on the list.
- E. IV is not on the list.
Built to the NABP blueprint
The NABP NAPLEX Content Outline (effective 1 May 2025) weights the exam across five areas. This practice exam follows the same weights, so your score by area shows where you stand against how the real exam is distributed. It is shorter than the real exam and is not adaptive. Check the current NABP candidate bulletin for anything administrative, because NABP can change it.
Is this for you?
Yes, if…
You are preparing for the NAPLEX and want a realistic, case-based check of where you stand by content area, with explanations that teach the reasoning.
No, if…
You are looking for released or recalled NABP questions. These questions are original, modeled on the NAPLEX style and blueprint. They are not NABP items. If you are preparing for the MPJE instead, see the UMPJE practice exam.
Questions before you buy
What if it isn't right for me?
Email support@doctayo.com within 30 days and you get your money back in full. See the refund policy.
What format is it?
A 65-page PDF, delivered by email immediately after purchase. Your copy carries your email address and order number on each page, so please do not share it. There is no subscription and no expiry.
Are these real NAPLEX questions?
No. Every question is original and written for this exam. They follow the NAPLEX style (a short case, five options, one best answer) and the NABP content weighting, but they are not released or recalled NABP items.
Does a good score mean I will pass?
No. NABP sets the real passing standard and this exam is shorter and not adaptive. Use your area scores to see where your preparation is thin.
How current is it?
Questions were written in November 2026 from FDA labeling and current guidelines, and each explanation lists its source basis and, where a source could be checked, a reference number. Drug information changes, so confirm anything you rely on in practice at the source. If you find an error, email support@doctayo.com.
See where you stand.
100 questions · every option explained · scored by NABP area
Digital download · Immediate access · 30-day money-back guarantee